Upcoming Biotech FDA Date for August 2009

I've put together an August '09 calender for the expected upcoming biotech FDA Decisions.

FDA Approval decision on a drug is a tremendous impact and huge significance for any biotech pharma, especially small cap biotech, for their years of research,labor and costs. Therefore, these FDA approval dates can be a make or break day for the company and demand great interest from investors for their company future valuation for the potential drug.

Nuvo Research Inc (biotech ticker: NRIFF)& Covidien (biotech ticker: COV)
FDA Decision Date: August 5 2009
Drug: Pennsaid (diclofenac sodium) topical solution

Updated: FDA extends NRIFF/COV new action date of Nov 4 2009.


NeurogesX Inc (biotech ticker: NGSX)
FDa Decision Date: August 16, 2009
Drug: Quentza for neuropathic pain

Auxilium Pharmaceuticals (biotech ticker: AUXL)
FDA Decision Date: August 28, 2009
Drug: Xiaflex for Dupuytren's contracture

Update: AUXL announced that FDA Arthritis Advisory Committee will reviewed Xiaflex on September 16 2009. FDA has not updated it new action date of August 28 2009.

I will update the next blog for this whole year soon, check back soon.